• NRNP 6568 Week 7 Knowledge Check Question 1
1 out of 1 points
Alopecia of outer one third of eyebrow and myxedema is are symptoms
of:
Selected
Answer: Hypothyroidism
Answers:
Hyperthyr
oidis m
Thyroid CA
Hypothyroid
• Question 2 ism
Thyrotoxico 1 out of 1 points
sis
Insulin doses typically remain the same when a woman with Type 1
Diabetes Mellitus becomes pregnant. True or False?
Selected
Answer:
Fal
se
Answers: True
Fal
se
• Question 3
1 out of 1 points
What are the primary purpose of periodic examination of patients with
known Diabetes Mellitus?
Selected
Answer: evaluate blood glucose control; to assess for end-
organ damage; to assess for associated diseases
, Answers
:
evaluate h blood h glucose h control; h to h assess h for h end-
organ h damage; h tohassess h for h associated h diseases
reverse h end h organ h damage, h prevent h renal h
dysfunction, h escalate h drughtherapy
wean h off h diabetic h medications h to h prevent h tolerance, h
reverse h end h organhdamage, h evaluate h blood h glucose h
control
reverse h end h organ h damage, h escalate h drug h therapy, h
meet h qualityhreporting h requirements
1 out of 1 points
Alopecia of outer one third of eyebrow and myxedema is are symptoms
of:
Selected
Answer: Hypothyroidism
Answers:
Hyperthyr
oidis m
Thyroid CA
Hypothyroid
• Question 2 ism
Thyrotoxico 1 out of 1 points
sis
Insulin doses typically remain the same when a woman with Type 1
Diabetes Mellitus becomes pregnant. True or False?
Selected
Answer:
Fal
se
Answers: True
Fal
se
• Question 3
1 out of 1 points
What are the primary purpose of periodic examination of patients with
known Diabetes Mellitus?
Selected
Answer: evaluate blood glucose control; to assess for end-
organ damage; to assess for associated diseases
, Answers
:
evaluate h blood h glucose h control; h to h assess h for h end-
organ h damage; h tohassess h for h associated h diseases
reverse h end h organ h damage, h prevent h renal h
dysfunction, h escalate h drughtherapy
wean h off h diabetic h medications h to h prevent h tolerance, h
reverse h end h organhdamage, h evaluate h blood h glucose h
control
reverse h end h organ h damage, h escalate h drug h therapy, h
meet h qualityhreporting h requirements